We have also described an EV surface functionalization approach that facilitates EGFR‐targeted delivery of paclitaxel‐loaded RBCEVs to EGFR‐positive lung cancer cells and increases treatment efficacy in vivo (Pham et al., 2021). This evidence concerns the gene EGFR and lung cancer.